TranSenda International LLC, a provider of clinical trial management software (CTMS) solutions, has been sold to BioClinica, a global provider of clinical trial management services, for an undisclosed consideration.
This acquisition is strategic in improving efficiencies for BioClinica's customers by reducing study duration and costs through integrated operational management.
Oaklins' team in Seattle initiated the transaction, assisted in the negotiations and acted as financial advisor to the seller in this transaction.
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.